Senseera
- Diagnostics
- Biotech or pharma, therapeutic R&D
Senseera has developed a first-in-class, AI-driven chromatin liquid biopsy platform that surpasses existing technologies by providing genome-wide, high-resolution insights into dynamic cell states.